Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development

When administered as standard three-dose schedules, the licensed HPV prophylactic vaccines have demonstrated extraordinary immunogenicity and efficacy. We summarize the immunogenicity of these licensed vaccines and the most commonly used serology assays, with a focus on key considerations for one-do...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Ligia A., Dillner, Joakim, Beddows, Simon, Unger, Elizabeth R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050153/
https://www.ncbi.nlm.nih.gov/pubmed/29361344
http://dx.doi.org/10.1016/j.vaccine.2017.11.089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050153/
https://www.ncbi.nlm.nih.gov/pubmed/29361344
http://dx.doi.org/10.1016/j.vaccine.2017.11.089

Ejemplares similares